Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Treatment
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global MF Market Portraiture
2.2. Global MF Market, by Treatment, 2018 (US$ Mn)
2.3. Global MF Market, by Geography, 2018 (US$ Mn)
Chapter 3. Mycosis Fungoides (MF) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Analysis: Global MF Market, by Key Players, 2018
Chapter 4. Global Mycosis Fungoides (MF) Market, by Treatment
4.1. Overview
4.2. Topical Steroids
4.3. Mechlorethamine gel
4.4. HDAC Inhibitors
4.5. Monoclonal Antibodies
4.6. Localized Radiation Therapy
4.7. Extracorporeal Photopheresis
4.8. Others
4.9. Pipeline Analysis
4.9.1. Phase III Drug
4.9.1.1. SGX301
4.9.1.2. Naloxone Hydrochloride Lotion 0.5%
4.9.2. Tabular Representation of Phase I and II Drug Pipeline
Chapter 5. Global Mycosis Fungoides (MF) Market, by Geography
5.1. Overview
5.2. North America MF Market Analysis, 2017 – 2027
5.2.1. North America MF Market, by Treatment, 2017 – 2027 (US$ Mn)
5.2.2. North America MF Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe MF Market Analysis, 2017– 2027
5.3.1. Europe MF Market, by Treatment, 2017 – 2027 (US$ Mn)
5.3.2. Europe MF Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific MF Market Analysis, 2017 – 2027
5.4.1. Asia Pacific MF Market, by Treatment, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific MF Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America MF Market Analysis, 2017 – 2027
5.5.1. Latin America MF Market, by Treatment, 2017 – 2027 (US$ Mn)
5.5.2. Latin America MF Market, by Country/Region, 2017 – 2027 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa MF Market Analysis, 2017 – 2027
5.6.1. MEA MF Market, by Treatment, 2017 – 2027 (US$ Mn)
5.6.2. MEA MF Market, by Region, 2017– 2027 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Astellas Pharma
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Bayer AG
6.3. Dover Medical and Scientific Equipment, Ltd.
6.4. Elorac, Inc.
6.5. Kyowa Kirin, Inc.
6.6. Macopharma
6.7. Sanofi SA
6.8. Soligenix, Inc.
6.9. Varian Medical Systems
6.10. Yaupon Therapeutics
List of Figures
FIG. 1 Mycosis Fungoides (MF) Market: Research Methodology
FIG. 2 MF: Market Segmentation
FIG. 3 Global MF Market, by Treatment, 2018 (US$ Mn)
FIG. 4 Global MF Market, by Geography, 2018 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2018
FIG. 6 Competitive Analysis: Global MF Market, by Key Players, 2018
FIG. 7 Global Topical Steroids Market for MF, 2017 – 2027 (US$ Mn)
FIG. 8 Global Mechlorethamine Gel Market for MF, 2017 – 2027 (US$ Mn)
FIG. 9 Global HDAC Inhibitors Market for MF, 2017 – 2027 (US$ Mn)
FIG. 10 Global Monoclonal Antibodies Market for MF, 2017– 2027 (US$ Mn)
FIG. 11 Global Localized Radiation Therapy Market for MF, 2017 – 2027 (US$ Mn)
FIG. 12 Global Extracorporeal Photopheresis Market for MF, 2017 – 2027 (US$ Mn)
FIG. 13 Global Other Treatment Market for MF, 2017 – 2027 (US$ Mn)
FIG. 14 U.S. MF Market, 2017 – 2027 (US$ Mn)
FIG. 15 Canada MF Market, 2017 – 2027 (US$ Mn)
FIG. 16 U.K. MF Market, 2017 – 2027 (US$ Mn)
FIG. 17 Germany MF Market, 2017 – 2027 (US$ Mn)
FIG. 18 Rest of Europe MF Market, 2017 – 2027 (US$ Mn)
FIG. 19 China MF Market, 2017– 2027 (US$ Mn)
FIG. 20 Japan MF Market, 2017 – 2027 (US$ Mn)
FIG. 21 Rest of Asia Pacific MF Market, 2017 – 2027 (US$ Mn)
FIG. 22 Brazil MF Market, 2017 – 2027 (US$ Mn)
FIG. 23 Mexico MF Market, 2017 – 2027 (US$ Mn)
FIG. 24 Rest of Latin America MF Market, 2017 – 2027 (US$ Mn)
FIG. 25 GCC MF Market, 2017 – 2027 (US$ Mn)
FIG. 26 Rest of Middle East and Africa MF Market, 2017 – 2027 (US$ Mn)
List of Tables
TABLE 1 Global Mycosis Fungoides (MF) Market Portraiture
TABLE 2 Global MF Market, by Treatment, 2017 – 2027 (US$ Mn)
TABLE 3 Global MF Market, by Geography, 2017 – 2027 (US$ Mn)
TABLE 4 North America MF Market, by Treatment, 2017 – 2027 (US$ Mn)
TABLE 5 North America MF Market, by Country, 2017 – 2027 (US$ Mn)
TABLE 6 Europe MF Market, by Treatment, 2017 – 2027 (US$ Mn)
TABLE 7 Europe MF Market, by Country/Region, 2017– 2027 (US$ Mn)
TABLE 8 Asia Pacific MF Market, by Treatment, 2017 – 2027 (US$ Mn)
TABLE 9 Asia Pacific MF Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 10 Latin America MF Market, by Treatment, 2017 – 2027 (US$ Mn)
TABLE 11 Latin America MF Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 12 Middle East and Africa MF Market, by Treatment, 2017– 2027 (US$ Mn)
TABLE 13 Middle East and Africa MF Market, by Region, 2017 – 2027 (US$ Mn)
TABLE 14 Astellas Pharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Dover Medical and Scientific Equipment, Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Elorac, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Kyowa Kirin, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Macopharma: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Sanofi S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Soligenix, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Varian Medical Systems: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Yaupon Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)